Ixchiq Side Effects

Generic name: chikungunya vaccine, live (cvx 317)

Medically reviewed by Drugs.com. Last updated on Mar 13, 2024.

Note: This document contains side effect information about chikungunya vaccine, live (cvx 317). Some dosage forms listed on this page may not apply to the brand name Ixchiq.

Applies to chikungunya vaccine, live (cvx 317): intramuscular solution.

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Chikungunya vaccine may cause low white blood cell counts. This usually occurs within the first week after receiving the vaccine. Tell your doctor if you have fever, mouth sores, skin sores, sore throat or cough. Your white blood cell counts may return to normal within 1 month.

You may have a severe reaction after receiving the vaccine. Call your doctor at once if you have fever, weakness, tiredness, headache, or severe muscle, back or joint pain. These symptoms may prevent you from daily activities, require a hospital stay, or last for weeks or months.

Common side effects may include:

• pain, redness, swelling, or tenderness where the vaccine was injected;

• headache, fever, weakness, tiredness; or

• muscle or joint pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to chikungunya vaccine, live (cvx 317): intramuscular solution.

General

The most commonly reported side effects included headache, fatigue, myalgia, and arthralgia.^[Ref]

Cardiovascular

Uncommon (0.1% to 1%): Peripheral edema, atrial fibrillation, severe atrial fibrillation

Frequency not reported: Tachycardia^[Ref]

Dermatologic

Common (1% to 10%): Rash

Uncommon (0.1% to 1%): Hyperhidrosis, erythematous rash

Frequency not reported: Severe rash^[Ref]

Gastrointestinal

Very common (10% or more): Nausea (up to 11.2%)

Common (1% to 10%): Vomiting, diarrhea

Frequency not reported: Severe nausea, severe vomiting^[Ref]

Hematologic

Very common (10% or more): Grade 1 abnormal neutrophil results (up to 27.6%) grade 1 abnormal leukocyte results (up to 27.3%), grade 1 abnormal lymphocyte results (up to 19.1%), grade 2 abnormal neutrophil results (up to 11.3%)

Common (1% to 10%): Grade 2 abnormal leukocyte results, grade 3 abnormal neutrophil results, grade 2 abnormal lymphocyte results

Uncommon (0.1% to 1%): Grade 3 abnormal leukocyte results, grade 4 abnormal neutrophil results, grade 3 abnormal lymphocyte results, lymphadenopathy^[Ref]

Immunologic

Uncommon (0.1% to 1%): Influenza-like illness

Frequency not reported: Chikungunya-like adverse reactions^[Ref]

Local

Very common (10% or more): Injection site tenderness (up to 10.6%)

Common (1% to 10%): Injection site pain, injection site erythema/redness (at least 2.5 cm), injection site induration (at least 2.5 cm)

Uncommon (0.1% to 1%): Injection site swelling (at least 2.5 cm)

Rare (0.01% to 0.1%): Severe injection site pain

Frequency not reported: Severe injection site tenderness^[Ref]

Metabolic

Frequency not reported: Hypovolemic hyponatremia, increased brain natriuretic peptide^[Ref]

Musculoskeletal

Very common (10% or more): Myalgia/muscle pain (up to 23.9%), arthralgia (up to 17.2%)

Common (1% to 10%): Chills, back pain

Uncommon (0.1% to 1%): Severe myalgia/muscle pain, severe arthralgia/joint pain, severe back pain

Frequency not reported: Mild arthralgia, increased troponin, arthritis^[Ref]

Nervous system

Very common (10% or more): Headache (up to 31.6%)

Uncommon (0.1% to 1%): Severe headache, dizziness, paresthesia, ataxia, hypoesthesia, peripheral neuropathy, syncope

Frequency not reported: Prolonged arthralgia, polyarthralgia, nodular swelling of joints in fingers and foot^[Ref]

Other

Very common (10% or more): Fatigue (up to 28.1%), fever/pyrexia (up to 13.5%)

Common (1% to 10%): Pain

Uncommon (0.1% to 1%): Severe fatigue, severe/worse fever, asthenia, feeling abnormal

Frequency not reported: Prolonged fatigue, severe fever^[Ref]

Respiratory

Frequency not reported: Tachypnea^[Ref]

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer